Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Gross Profit: 2023-2025

Historic Gross Profit for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $89,000.

  • CG Oncology's Gross Profit rose 106.98% to $89,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $640,000, marking a year-over-year decrease of 6.43%. This contributed to the annual value of $1.1 million for FY2024, which is 458.33% up from last year.
  • CG Oncology's Gross Profit amounted to $89,000 in Q3 2025, which was up 71.15% from $52,000 recorded in Q1 2025.
  • In the past 5 years, CG Oncology's Gross Profit ranged from a high of $529,000 in Q1 2024 and a low of $1,000 during Q4 2023.
  • Over the past 3 years, CG Oncology's median Gross Profit value was $89,000 (recorded in 2025), while the average stood at $164,889.
  • As far as peak fluctuations go, CG Oncology's Gross Profit soared by 45,500.00% in 2024, and later plummeted by 90.17% in 2025.
  • Quarterly analysis of 3 years shows CG Oncology's Gross Profit stood at $1,000 in 2023, then spiked by 45,500.00% to $456,000 in 2024, then surged by 106.98% to $89,000 in 2025.
  • Its Gross Profit stands at $89,000 for Q3 2025, versus $52,000 for Q1 2025 and $456,000 for Q4 2024.